Integrated Diagnostics Holdings plc

IDHC

JE00BLKGSR75

Healthcare Facilities & Services

Delayed London S.E. Other stock markets 11:35:15 2024-05-20 am EDT			5-day change	1st Jan Change
0.32 ^USD	-0.16%		+0.95%	-9.86%

May. 16	EARNINGS AND TRADING: Tullow Oil on track to hit free cash flow target	AN
May. 16	Integrated Diagnostics Holdings to Delist from Egypt Bourse	MT

Integrated Diagnostics Holdings plc Provides Earnings Guidance for the Year 2021

September 06, 2021 at 09:00 am EDT

Integrated Diagnostics Holdings plc provided earnings guidance for the year 2021. For the full year guidance growth for revenue to be in the range of 80%.

Latest news about Integrated Diagnostics Holdings plc

EARNINGS AND TRADING: Tullow Oil on track to hit free cash flow target	May. 16	AN
Integrated Diagnostics Holdings to Delist from Egypt Bourse	May. 16	MT
Integrated Diagnostics Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Transcript : Integrated Diagnostics Holdings plc, 2023 Earnings Call, Mar 28, 2024	Mar. 28
EARNINGS AND TRADING: Arbuthnot ups payout as profit more than doubles	Mar. 28	AN
Earnings Flash (IDHC.L) INTEGRATED DIAGNOSTICS HOLDINGS Reports FY23 EPS EGP0.85	Mar. 28	MT
EXECUTIVE CHANGES: Eco Buildings chair leaves and vice chair ousted	Jan. 18	AN
Integrated Diagnostics Holdings Names New CFO	Jan. 18	MT
Integrated Diagnostics Holdings Appoints Sherif El Zeiny as Board Member	Jan. 18	CI
Integrated Diagnostics Holdings Appoints Sherif El Zeiny as Group Chief Financial Officer	Jan. 18	CI
Transcript : Integrated Diagnostics Holdings plc, Q3 2023 Earnings Call, Nov 21, 2023	Nov. 21
EARNINGS AND TRADING: Integrated Diagnostics returns to profit	Nov. 16	AN
Integrated Diagnostics Returns to Profit in Q3; Revenue Up	Nov. 16	MT
Integrated Diagnostics Holdings plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 16	CI
Integrated Diagnostics CEO buys 2.0m shares	23-10-25	AN
Integrated Diagnostics CEO buys 1.1 million more shares	23-10-17	AN
Schroders CFO buys GBP300,000 in shares	23-10-16	AN
Integrated Diagnostics Holdings plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-31	CI
Gulf Keystone swings to loss; Gulf Marine optimistic	23-08-31	AN
Integrated Diagnostics Records Lower H1 Profit, Revenue	23-08-31	MT
Earnings Flash (IDHC.L) INTEGRATED DIAGNOSTICS HOLDINGS Posts H1 EPS EGP0.37	23-08-31	MT
Integrated Diagnostics Holdings Reaffirms Revenue Guidance for the Fiscal Year 2023	23-08-31	CI
FTSE 100 Closes Down 0.1% Amid UK Interest Rate Hike Fears	23-06-21	DJ
UK Public Finances Overshoot Give Chancellor Little Room for Giveaways	23-06-21	DJ
Integrated Diagnostics hires new CFO as Bedewy to depart	23-06-21	AN

Chart Integrated Diagnostics Holdings plc

Duration

Period

Chart Integrated Diagnostics Holdings plc

More charts

Integrated Diagnostics Holdings PLC is a consumer healthcare company. The Company operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The Company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, histopathology, genetics, radiology and others. The Companyâs brands include Al Borg Scan, Al Mokhtabar, Ultralab, Biolab, Echo-Lab and others. It operates in approximately 552 branches. It offers more than 3,000 diagnostics tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy and substance abuse. Through Al Borg Scan, it offers a full range of radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography-computed tomography (PET-CT), electromyography (EMG), electrocardiogram (ECG), electroencephalogram (EEG), ultrasound, x-ray, mammograms and cath lab facilities.

Sector

Healthcare Facilities & Services

Calendar

2024-05-29 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Integrated Diagnostics Holdings plc

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

14.93 EGP

Average target price

32.81 EGP

Spread / Average Target

+119.82%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
INTEGRATED DIAGNOSTICS HOLDINGS PLC	-9.86%	192M
HCA HEALTHCARE, INC.	+20.09%	85.14B
CVS HEALTH CORPORATION	-27.30%	72.06B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+2.96%	27.07B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-9.00%	17.43B
FRESENIUS SE & CO. KGAA	-2.28%	16.98B
QUEST DIAGNOSTICS INCORPORATED	+4.56%	16.02B
NATERA, INC.	+69.72%	13.06B
FRESENIUS MEDICAL CARE AG	+3.95%	12.9B
TENET HEALTHCARE CORPORATION	+73.30%	12.79B

Other Healthcare Facilities & Services